/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Neurona Therapeutics

Neurona Therapeutics

South San Francisco, United States

Neurona Therapeutics develops cell therapies for targeted repair of dysfunctional neural circuits underlying chronic diseases

Healthcare & Biotech

Neurona Therapeutics, based in South San Francisco, United States, has 2 investors on file, among them The Column Group and Ysios Capital. Its site was last checked 12 Nov 2026: site answers.

neuronatherapeutics.com

SEC Form D filings

6 filings
$102M sold4 Apr 2025$120M sold13 Feb 2024$72.0M sold of $91.6M offered23 Dec 2022$28.3M sold of $40.0M offered29 Mar 2021$15.0M sold of $50.0M offered25 Nov 2019$10.0M sold of $20.0M offered27 Feb 2018

Filed by NEURONA THERAPEUTICS, INC with the SEC. A Form D reports a private offering; it is not a priced round.

Investors

2 investors on file
InvestorEvidenceType
The Column GroupPortfolio pageVenture capital
Ysios CapitalPortfolio pageVenture capital

More from The Column Group

37 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (95%), Fintech (3%), E-commerce & Marketplaces (3%).

A2 BiotherapeuticsA2 Biotherapeutics is advancing a cell engineering platform to create …Accent TherapeuticsAccent Therapeutics develops small molecule therapeutics for patients …Arcus Biosciences, Inc.Arcus Biosciences creates medicines by advancing validated biology wit…Atavistik BioAtavistik Bio is a clinical-stage biotechnology company developing inn…Carmot Therapeutics

See The Column Group's full profile · Who invests alongside it

More from Ysios Capital

30 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (93%), Media & Entertainment (3%), Developer Tools (3%).

AdcendoAdcendo is developing a new generation of antibody-drug conjugates to …AmgenAmgen operates in the biotechnology industry, conducting research and …BabyscriptsBabyscripts provides a maternity care solution that uses early risk de…CVRXCVRx develops and implants a device to treat heart failureEngrail TherapeuticsEngrail Therapeutics is a clinical-stage pharmaceutical company that d…

See Ysios Capital's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Neurona Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when The Column Group adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/neuronatherapeutics.com/investors

# also
GET /v1/companies/neuronatherapeutics.com
GET /v1/companies/neuronatherapeutics.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing